OBJECTIVE: To develop a claims-based algorithm to identify undiagnosed chronic migraine among patients enrolled in a healthcare system. METHODS: An observational study using claims and patient survey data was conducted in a large medical group. Eligible patients had an International Classification of Diseases, Ninth/Tenth Revision (ICD-9/10) migraine diagnosis, without a chronic migraine diagnosis, in the 12 months before screening and did not have a migraine-related onabotulinumtoxinA claim in the 12 months before enrollment. Trained clinicians administered a semi-structured diagnostic interview, which served as the gold standard to diagnose chronic migraine, to enrolled patients. Potential claims-based predictors of chronic migraine that differentiated semi-structured diagnostic interview-positive (chronic migraine) and semi-structured diagnostic interview-negative (non-chronic migraine) patients were identified in bivariate analyses for inclusion in a logistic regression model. RESULTS: The final sample included 108 patients (chronic migraine = 64; non-chronic migraine = 44). Four significant predictors for chronic migraine were identified using claims in the 12 months before enrollment: ≥15 versus <15 claims for acute treatment of migraine, including opioids (odds ratio = 5.87 [95% confidence interval: 1.34-25.63]); ≥24 versus <24 healthcare visits (odds ratio = 2.80 [confidence interval: 1.08-7.25]); female versus male sex (odds ratio = 9.17 [confidence interval: 1.26-66.50); claims for ≥2 versus 0 unique migraine preventive classes (odds ratio = 4.39 [confidence interval: 1.19-16.22]). Model sensitivity was 78.1%; specificity was 72.7%. CONCLUSIONS: The claims-based algorithm identified undiagnosed chronic migraine with sufficient sensitivity and specificity to have potential utility as a chronic migraine case-finding tool using health claims data. Research to further validate the algorithm is recommended.
OBJECTIVE: To develop a claims-based algorithm to identify undiagnosed chronic migraine among patients enrolled in a healthcare system. METHODS: An observational study using claims and patient survey data was conducted in a large medical group. Eligible patients had an International Classification of Diseases, Ninth/Tenth Revision (ICD-9/10) migraine diagnosis, without a chronic migraine diagnosis, in the 12 months before screening and did not have a migraine-related onabotulinumtoxinA claim in the 12 months before enrollment. Trained clinicians administered a semi-structured diagnostic interview, which served as the gold standard to diagnose chronic migraine, to enrolled patients. Potential claims-based predictors of chronic migraine that differentiated semi-structured diagnostic interview-positive (chronic migraine) and semi-structured diagnostic interview-negative (non-chronic migraine) patients were identified in bivariate analyses for inclusion in a logistic regression model. RESULTS: The final sample included 108 patients (chronic migraine = 64; non-chronic migraine = 44). Four significant predictors for chronic migraine were identified using claims in the 12 months before enrollment: ≥15 versus <15 claims for acute treatment of migraine, including opioids (odds ratio = 5.87 [95% confidence interval: 1.34-25.63]); ≥24 versus <24 healthcare visits (odds ratio = 2.80 [confidence interval: 1.08-7.25]); female versus male sex (odds ratio = 9.17 [confidence interval: 1.26-66.50); claims for ≥2 versus 0 unique migraine preventive classes (odds ratio = 4.39 [confidence interval: 1.19-16.22]). Model sensitivity was 78.1%; specificity was 72.7%. CONCLUSIONS: The claims-based algorithm identified undiagnosed chronic migraine with sufficient sensitivity and specificity to have potential utility as a chronic migraine case-finding tool using health claims data. Research to further validate the algorithm is recommended.
Entities:
Keywords:
Chronic migraine; case-finding tool; diagnosis predictors; health claims data
Authors: R B Lipton; S F Varon; B Grosberg; P J McAllister; F Freitag; S K Aurora; D W Dodick; S D Silberstein; H C Diener; R E DeGryse; M E Nolan; C C Turkel Journal: Neurology Date: 2011-09-28 Impact factor: 9.910
Authors: Thomas S Rector; Steven L Wickstrom; Mona Shah; N Thomas Greeenlee; Paula Rheault; Jeannette Rogowski; Vicki Freedman; John Adams; José J Escarce Journal: Health Serv Res Date: 2004-12 Impact factor: 3.402
Authors: A M Blumenfeld; S F Varon; T K Wilcox; D C Buse; A K Kawata; A Manack; P J Goadsby; R B Lipton Journal: Cephalalgia Date: 2010-09-02 Impact factor: 6.292
Authors: Michael Stokes; Werner J Becker; Richard B Lipton; Sean D Sullivan; Teresa K Wilcox; Leandra Wells; Aubrey Manack; Irina Proskorovsky; Jonathan Gladstone; Dawn C Buse; Sepideh F Varon; Peter J Goadsby; Andrew M Blumenfeld Journal: Headache Date: 2011 Jul-Aug Impact factor: 5.887
Authors: S Cevoli; D D'Amico; P Martelletti; F Valguarnera; E Del Bene; R De Simone; P Sarchielli; Mc Narbone; L Testa; S Genco; G Bussone; P Cortelli Journal: Cephalalgia Date: 2009-05-11 Impact factor: 6.292
Authors: Jelena M Pavlovic; Justin S Yu; Stephen D Silberstein; Michael L Reed; Robert P Cowan; Firas Dabbous; Riya Pulicharam; Hema N Viswanathan; Richard B Lipton Journal: Headache Date: 2021-01-09 Impact factor: 5.887
Authors: Linda Harris; Gilbert L'Italien; Anil Kumar; Prafullakumar Seelam; Chris LaVallee; Vladimir Coric; Richard B Lipton Journal: Headache Date: 2022-03-28 Impact factor: 5.311